The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease

Current pharmacological therapy for Alzheimer’s disease (AD) includes the cholinesterase inhibitors (ChEIs) donepezil, rivastigmine, and galantamine and the N -methyl d -aspartate receptor antagonist memantine. Based on the results of randomized controlled trials and several meta-analyses, ChEIs app...

Full description

Saved in:

Bibliographic Details
Published in:	Drugs & aging Vol. 32; no. 7; pp. 537 - 547
Main Authors:	Deardorff, William James, Feen, Eliahu, Grossberg, George T.
Format:	Journal Article
Language:	English
Published:	Cham Springer International Publishing 01-07-2015 Springer Nature B.V
Subjects:	Aged, 80 and over Alzheimer Disease - diagnosis Alzheimer Disease - drug therapy Alzheimer Disease - enzymology Cholinesterase Inhibitors - therapeutic use Current Opinion Geriatrics/Gerontology Humans Internal Medicine Medicine Medicine & Public Health Pharmacology/Toxicology Pharmacotherapy Quality of Life Randomized Controlled Trials as Topic Memantine Mini Mental State Examination Rivastigmine Nursing Home Resident Cholinesterase Inhibitor
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!